These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 4901358)

  • 41. Immunity to Salmonella typhimurium infection in C3H/HeJ and C3H/HeNCrlBR mice: studies with an aromatic-dependent live S. typhimurium strain as a vaccine.
    Killar LM; Eisenstein TK
    Infect Immun; 1985 Mar; 47(3):605-12. PubMed ID: 3882560
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunization of calves against salmonellosis.
    Bairey MH
    J Am Vet Med Assoc; 1978 Sep; 173(5 Pt 2):610-3. PubMed ID: 359522
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An enterobacterial common antigen mutant of Salmonella enterica serovar Typhimurium as a vaccine candidate.
    Bridge DR; Whitmire JM; Gilbreath JJ; Metcalf ES; Merrell DS
    Int J Med Microbiol; 2015 Sep; 305(6):511-22. PubMed ID: 26070977
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Duration of immunity induced in chickens by an attenuated live Salmonella enteritidis vaccine and an inactivated Salmonella enteritidis/typhimurium vaccine.
    Springer S; Lindner T; Ahrens M; Woitow G; Prandini F; Selbitz HJ
    Berl Munch Tierarztl Wochenschr; 2011; 124(3-4):89-93. PubMed ID: 21462861
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of an outer membrane protein of Salmonella enterica serovar Typhimurium as a potential vaccine candidate for Salmonellosis in mice.
    Yang Y; Wan C; Xu H; Aguilar ZP; Tan Q; Xu F; Lai W; Xiong Y; Wei H
    Microbes Infect; 2013 May; 15(5):388-98. PubMed ID: 23485513
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of recombinant outer membrane protein based vaccine against Salmonella Typhimurium in birds.
    Prejit ; Agarwal RK; Porteen K; Dubal ZB; Asha K; Shweta S; Ripan B
    Biologicals; 2013 May; 41(3):162-8. PubMed ID: 23462815
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Degree of immunity induced by killed vaccines to experimental salmonellosis in mice.
    Herzberg M; Nash P; Hino S
    Infect Immun; 1972 Jan; 5(1):83-90. PubMed ID: 4570987
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative efficacy and toxicity of a ribosomal vaccine, acetone-killed cells, lipopolysaccharide, and a live cell vaccine prepared from Salmonella typhhimurium.
    Angerman CR; Eisenstein TK
    Infect Immun; 1978 Feb; 19(2):575-82. PubMed ID: 344216
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Protective action on mice of acellular extracts from Salmonella typhimurium].
    Golebiowski TE; Tinelli RL
    C R Acad Hebd Seances Acad Sci D; 1978 Jun; 286(22):1633-5. PubMed ID: 97021
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prime-boost vaccination with attenuated Salmonella Typhimurium ΔznuABC and inactivated Salmonella Choleraesuis is protective against Salmonella Choleraesuis challenge infection in piglets.
    Alborali GL; Ruggeri J; Pesciaroli M; Martinelli N; Chirullo B; Ammendola S; Battistoni A; Ossiprandi MC; Corradi A; Pasquali P
    BMC Vet Res; 2017 Sep; 13(1):284. PubMed ID: 28893256
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dual role for macrophages in vivo in pathogenesis and control of murine Salmonella enterica var. Typhimurium infections.
    Wijburg OL; Simmons CP; van Rooijen N; Strugnell RA
    Eur J Immunol; 2000 Mar; 30(3):944-53. PubMed ID: 10741413
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Endotoxicity does not limit the use of bacterial ghosts as candidate vaccines.
    Mader HJ; Szostak MP; Hensel A; Lubitz W; Haslberger AG
    Vaccine; 1997 Feb; 15(2):195-202. PubMed ID: 9066038
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mice vaccinated with a non-virulent, aromatic-dependent mutant of Salmonella choleraesuis die from challenge with its virulent parent but survive challenge with Salmonella typhimurium.
    Nnalue NA
    J Med Microbiol; 1990 Apr; 31(4):225-33. PubMed ID: 2139129
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cutting edge: role of B lymphocytes in protective immunity against Salmonella typhimurium infection.
    Mittrücker HW; Raupach B; Köhler A; Kaufmann SH
    J Immunol; 2000 Feb; 164(4):1648-52. PubMed ID: 10657605
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Artificial Salmonella vaccines: O-antigenic oligosaccharide-protein conjugates induce protection against infection with Salmonella typhimurium.
    Svenson SB; Nurminen M; Lindberg AA
    Infect Immun; 1979 Sep; 25(3):863-72. PubMed ID: 387597
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Detoxified bacterial endotoxns. II. Preparation and biological properties of chemically modified crude endotoxins from Salmonella typhimurium.
    Martin WJ; Marcus S
    J Bacteriol; 1966 May; 91(5):1750-8. PubMed ID: 4287071
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Design of glycoconjugate vaccines against invasive African Salmonella enterica serovar Typhimurium.
    Rondini S; Micoli F; Lanzilao L; Gavini M; Alfini R; Brandt C; Clare S; Mastroeni P; Saul A; MacLennan CA
    Infect Immun; 2015 Mar; 83(3):996-1007. PubMed ID: 25547792
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of a
    Zafar H; Rahman SU; Ali S; Javed MT
    Pol J Microbiol; 2019; 68(2):173-183. PubMed ID: 31257790
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunobiology of lipopolysaccharide (LPS) and LPS-derived immunoconjugates vaccinate mice against Salmonella typhimurium.
    Tiwari RP; Gupta W; Rishi P
    Microbiol Immunol; 1998; 42(1):1-5. PubMed ID: 9525773
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protection against mouse typhoid by artificial Salmonella vaccines.
    Svenson SB; Lindberg AA
    Scand J Infect Dis Suppl; 1980; Suppl 24():210-5. PubMed ID: 6163199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.